|
|
|||||||||
Department of Radiology, Division of Nuclear Medicine, University of Alabama at Birmingham Medical Center, Birmingham, Alabama
Correspondence: For correspondence or reprints contact: James M. Mountz, MD, PhD, University of Alabama at Birmingham Medical Center, Division of Nuclear Medicine, 619 S. 19th St., JT J260, Birmingham, AL 35233-6835.
ABSTRACT
Primary progressive aphasia (PPA) is an uncommon degenerative dementia characterized by gradual impairment of language function with initial sparing of the memory domain. Using semi-quantitative 99mTc-hexamethyl propyleneamine oxime (HMPAO) brain SPECT as a measure of regional cerebral blood flow (rCBF), we investigated the relationship between reduced 99mTc-HMPAO uptake and the severity of dysnomia in PPA. Methods: Seven light-handed patients with PPA had their dysnomia assessed by the Boston Naming Test (BNT), a subtest of the Boston Diagnostic Aphasia Examination. Neuroimaging studies, including Tc-HMPAO brain SPECT, CT, and MRI, were performed. Correlational analysis between reduced rCBF and BNT was performed. Results: Brain SPECT showed a reduction in 99mTc-HMPAO uptake involving the frontal and temporal lobes in all 7 patients. CT and MRI showed mild to moderate cerebral atrophy in 4 patients. Low scores on the BNT correlated with low frontotemporal 99mTc-HMPAO (Spearman r = 0.97, P = 0.004) in the 5 patients with left-hemisphere involvement. Conclusion: Decreased rCBF to the frontotemporal region characterized the cerebral abnormalities associated with PPA. The finding of focal rCBF abnormalities in the right hemisphere of 2 right-handed women corroborates that PPA symptoms may arise from a "non-left-dominant"-hemisphere degenerative process. Our results support the usefulness of rCBF SPECT imaging as a diagnostic aid in PPA.
Key Words: progressive aphasia 99mTc-HMPAO brain SPECT Boston Naming Test
This article has been cited by other articles:
![]() |
P.K. Panegyres, M. McCarthy, A. Campbell, N. Lenzo, M. Fallon, and J. Thompson Correlative Studies of Structural and Functional Imaging in Primary Progressive Aphasia American Journal of Alzheimer's Disease and Other Dementias, May 1, 2008; 23(2): 184 - 191. [Abstract] [PDF] |
||||
![]() |
M. Mesulam, S. Weintraub, T. Parrish, and D. Gitelman Primary progressive aphasia: Reversed asymmetry of atrophy and right hemisphere language dominance Neurology, February 8, 2005; 64(3): 556 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sudo, M. Sasaki, K. Sugai, and H. Matsuda Therapeutic effect and [123I]IMP SPECT findings of sodium dichloroacetate in a patient with MELAS Neurology, January 27, 2004; 62(2): 338 - 339. [Full Text] [PDF] |
||||
![]() |
M.-H. Soriani-Lefevre, D. Hannequin, S. Bakchine, J.-F. Menard, A. Manrique, A. Hitzel, P.-O. Kotzki, V. Boudousq, and P. Vera Evidence of Bilateral Temporal Lobe Involvement in Primary Progressive Aphasia: A SPECT Study J. Nucl. Med., July 1, 2003; 44(7): 1013 - 1022. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |